Literature DB >> 3481660

Time courses of the antithrombotic effects, bleeding enhancing effects and interactions with factors Xa and thrombin after administration of low molecular weight heparinoid Org 10172 or heparin to rats.

P M Hobbelen1, G M Vogel, D G Meuleman.   

Abstract

Time response curves of the anti-thrombotic effects, bleeding enhancing effects, effects on APTT, anti-Xa activities, anti-thrombin activities and thrombin generation inhibitory activities of the low molecular weight heparinoid Org 10172 and heparin have been compared in rats. The time courses of these effects were similar for heparin but quite different for Org 10172. Org 10172 induced anti-thrombotic and anti-Xa effects which lasted approximately 3 times longer than those at the same anti-Xa doses of heparin, whereas the bleeding enhancing effects and effects on APTT of Org 10172 were of shorter duration than those of heparin. The half-life of the anti-thrombin effect after Org 10172 seemed somewhat longer than after heparin administration. Thrombin generation inhibition by Org 10172 showed a slightly longer duration than by heparin. The similarities between the time courses of the anti-thrombotic effect and the anti-Xa activity after Org 10172 administration suggest that the most appropriate parameter to monitor Org 10172 treatment is the plasma anti-Xa level.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3481660     DOI: 10.1016/0049-3848(87)90386-0

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  5 in total

1.  The influence of Org 10172, a low molecular weight heparinoid, on antipyrine metabolism and the effect of enzyme induction on the response to Org 10172.

Authors:  A De Boer; J C Stiekema; M Danhof; D D Breimer
Journal:  Br J Clin Pharmacol       Date:  1991-07       Impact factor: 4.335

Review 2.  Danaparoid. A review of its pharmacology and clinical use in the management of heparin-induced thrombocytopenia.

Authors:  M I Wilde; A Markham
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

3.  Studies of interaction of a low-molecular-weight heparinoid (Org 10172) with cloxacillin and ticarcillin in healthy male volunteers.

Authors:  A de Boer; J C Stiekema; M Danhof; T G van Dinther; J K Boeijinga; A F Cohen; D D Breimer
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

4.  Interaction of ORG 10172, a low molecular weight heparinoid, and digoxin in healthy volunteers.

Authors:  A de Boer; J C Stiekema; M Danhof; A J Moolenaar; D D Breimer
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 5.  Direct Oral Anticoagulants in Cirrhotic Patients: Current Evidence and Clinical Observations.

Authors:  Sherif Elhosseiny; Hassan Al Moussawi; Jean M Chalhoub; James Lafferty; Liliane Deeb
Journal:  Can J Gastroenterol Hepatol       Date:  2019-01-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.